Posts Tagged ‘ISCI’
Suzuki Receives 2023 AstraZeneca Lung Cancer Research Award
The Board of Directors of The Thoracic Surgery Foundation has named Kei Suzuki, MD, the recipient of the 2023 AstraZeneca Lung Cancer Research Award. Suzuki was recognized for his project, “Single-cell RNA sequence profiling of tumor-immune microenvironment for precision therapy in resectable lung cancer.” “This funding is crucial to take the research to the next…
Read MoreLife with Cancer Couples’ Therapy Helps Patients and Partners Thrive
There’s no question that a cancer diagnosis is a stressful life event. The person with cancer may feel a mix of complex emotions, including processing how and when to share these feelings with people around them. Their treatment journey can cause upheaval at work and at home, and can create worry about how their relationships…
Read MoreBreathing Easier with Interventional Pulmonology
Interventional pulmonology provides minimally invasive techniques to help diagnose and treat lung diseases. Your lungs bring oxygen into the body and remove carbon dioxide waste. Many different diseases impair lung function and diminish a person’s quality of life. The Interventional Pulmonology (IP) program at Inova Schar Cancer Institute provides minimally invasive procedures and therapies to…
Read MoreUnderstanding Risk: The First Step in Breast Cancer Prevention
Rebecca Kaltman, MD is a board-certified hematologist oncologist. She serves as the Medical Director of the Inova Saville Cancer Screening and Prevention Center. If there was just one thing I could say to a woman who asked me what she should do to prevent breast cancer, it would be simple: Know your risk. Knowing your…
Read MoreEndurance Sports and Colorectal Cancer: Is There a Connection?
Timothy L. Cannon, MD, is board certified in medical oncology, hematology and internal medicine. He serves as the Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program. After treating three ultramarathoners who had developed colorectal cancer in recent years, I had a suspicion: This could be more than a coincidence. I found…
Read MoreInova Saville Cancer Screening and Prevention Center Joins an International Effort to Fight Pancreatic Cancer
Raymond Wadlow, MD, is an oncologist at Inova Schar Cancer Institute. He is board-certified in Medical Oncology and Internal Medicine and has a special interest in gastrointestinal oncology. We know the realities of pancreatic cancer. It is a disease that caused 48,220 deaths in the United States in 2021, and 466,003 worldwide in 2020. It…
Read MoreInova’s Thyroid Nodule Clinic Aims for Seamless, Expedited Care
Jina Kim, MD is a general surgeon and fellowship-trained in endocrine surgery. She is a member of the Inova Endocrine Tumor Program team at Inova Schar Cancer Institute. One message I emphasize when I talk about thyroid cancer is that it is very treatable. The outcome for most patients with papillary and follicular thyroid cancers…
Read MoreBy Fighting Skin Cancer Misconceptions, We Can Screen More Patients and Save More Lives
Patricia Lucey, MD, is a board-certified dermatologist at the Inova Melanoma and Skin Cancer Center. She has a special interest in the diagnosis and management of melanoma and other skin cancers. Skin cancer is the most prevalent form of cancer in the United States — a fact that can sound discouraging. But another fact we know…
Read MoreIs Prostate Cancer Slow Growing? Often, Yes — But That’s Not the Whole Story
Prostate cancer, unlike other forms of cancer, often grows slowly. That fact can make screening, treatment and potential outcomes seem a little less intimidating. However, prostate cancer’s slow-growing tendency can obscure other, more complicated aspects of detection and treatment. First, decisions on when to get screened and how to respond to the results are complex,…
Read MoreStudy Finds New Therapy Effective for Common, Advanced Bladder Cancer
Following standard chemotherapy, Avelumab was found to increase the overall survival of patients with advanced urothelial bladder cancer. According to the North American Association of Central Cancer Registries, more than 80,000 Americans will be diagnosed with bladder cancer in 2022 with an anticipated loss of 17,000 patients to the disease. Most of these cases are…
Read More